FDA Issues EUA to Baricitinib Plus Remdesivir for COVID-19
Emergency use authorization applies to hospitalized patients requiring supplemental oxygen, mechanical ventilation, ECMO
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.